<DOC>
	<DOCNO>NCT00606905</DOCNO>
	<brief_summary>Recurrent miscarriage prevalent reproductive problem affect many couple try establish family . This clinical study evaluate effectiveness intravenous immunoglobulin ( IVIG ) improve live birth rate couple suffer secondary recurrent miscarriage . This study help provide answer question whether IVIG helpful secondary recurrent miscarriage .</brief_summary>
	<brief_title>Intravenous Immunoglobulin ( IVIG ) Treatment Unexplained Secondary Recurrent Miscarriage</brief_title>
	<detailed_description>The purpose multi-center trial evaluate efficacy IVIG improve ongoing pregnancy ( &gt; 20 week gestation ) rate couple unexplained secondary recurrent miscarriage , ; characterize compare pharmacokinetic pharmacodynamic parameter IVIG pre-conceptually 1st 2nd trimester pregnancy , improve IVIG dose strategy determine .</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Couple history unexplained secondary recurrent miscarriage . Most recent pregnancy occur within one year discontinue contraception . Maternal IgA deficiency Maternal history immunoglobulin hypersensitivity . Maternal contraindication pregnancy . Evidence active hepatitis immunocompromised state either partner . Concomitant use medication ( ) treatment recurrent miscarriage , limited progesterone , clomiphene citrate , acetylsalicylic acid , heparin , glucocorticoid hCG injection .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Recurrent miscarriage</keyword>
	<keyword>Recurrent spontaneous abortion</keyword>
	<keyword>Habitual abortion</keyword>
	<keyword>IVIG</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>